Pharmafile Logo
Pharmafocus logo
Advanced Search

inhaled insulin

Showing 6 posts of 6 posts found.

samsung_bioepis

South Korea jails executives for their role in Samsung Biologics fraud

December 10, 2019
Manufacturing and Production Samsung phones, Sanofi, Sanofi Diabetes, South Korea Healthcare System, South Korea Samsung, diabetes, inhaled insulin, insulin, south korea

Three executives of Samsung Electronics have been sentenced to jail for their role in committing fraud at its biotech affiliate …

News
manufacturing_compounding

Mannkind’s inhaled insulin Afrezza edges closer to market

August 19, 2013
Research and Development, Sales and Marketing Afrezza, Exubera, Mannkind, inhaled insulin

News

Afrezza could breathe new life into inhaled insulin market

August 15, 2011
Research and Development, Sales and Marketing diabetes, inhaled insulin, insulin, research and development news

New trials for MannKind’s investigational inhaled insulin drug Afrezza have been given the go-ahead by the FDA, potentially breathing new …

News

Pfizer abandons Exubera

October 19, 2007
Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin

Once predicted to be a blockbuster, inhaled insulin product Exubera is to be abandoned by Pfizer because of poor sales.Exubera …

News

Exubera approval limited to needle-phobic patients

January 26, 2007
Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin

 Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …

News

Pfizer to go it alone with Exubera

January 16, 2006
Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin

 Pfizer has paid $1.3 billion to buy out its marketing partner’s stake in new inhaled diabetes drug Exubera.The US company …

News

Latest content

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024